NASDAQ: EDIT · Biotechnology
Over the past week, Editas Medicine (EDIT) logged 12 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 42% bullish but is far apart: News runs 75% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 7 of 13 analysts rating EDIT a buy.
There is little buzz around EDIT this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 54% buy share sits next to a crowd that ranges from Reddit at 0% to News at 75%. No other tracker puts the two side by side.
Across 13 analysts the consensus is a Buy: 7 buy calls against 2 sell, with an average 12-month price target of $5.90.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 12 points above the crowd average of 42%, the professionals are more constructive than retail. The split is inside the crowd: News reads 75% bullish while Reddit sits at 0%, a 75-point spread that single-source trackers miss.
Over the 30-day window, Editas Medicine (EDIT) buzz held subdued around 26.5 while the price drifted down 18.4% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 3.2M shares. Updated Sep 26, 2026. Over the last 7 trading days, EDIT lost 5.1%. Buzz activity in the recent week averaged 34.2 and was relatively stable, swinging between 26.5 and 45.9. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 8 of the 12 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for EDIT and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live EDIT sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 26, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Buy (7 / 4 / 2) |
| Crowd bullish (7d) | 42% |
| Avg price target | $5.90 |
| Most bullish source | News, 75% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 75 pts |
| Mentions (7d) | 12 |
| Market cap | $422.3M |
| EPS · Beta | -$0.68 · 2.1 |
| Revenue (TTM) | $47M · -157% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Editas Medicine (EDIT) currently carries an Adanos hold signal with 71/100 conviction. The current cross-source average reads 42% bullish across 3 active sources. Those sources contribute 12 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Editas Medicine (EDIT) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 3 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Editas Medicine (EDIT), averaging 42% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 75% bullish and Reddit at 0%, a 75-point spread. On the professional side, 7 of 13 analysts rate EDIT a buy.
Of the 13 analysts covering Editas Medicine (EDIT), 7 rate it a buy, 4 a hold and 2 a sell, for a buy consensus. The average price target is $5.90. That puts the street ahead of the crowd, which averages 42% bullish.
Editas Medicine (EDIT)'s cross-source average is bearish at 42% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. X reads 50% bullish, News reads 75% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad mixed pressure with 71/100 conviction.
The cross-source average is bearish for Editas Medicine (EDIT) at 42% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. The most bearish reading is reddit at 0% bullish. The hold signal carries 71/100 conviction.
X is the dominant discussion channel with 8 mentions (67% of total volume). News contributes 4 mentions. The cross-source average is bearish at 42% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. EDIT's hold signal at 71/100 conviction reflects a bearish cross-source average at 42% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The EDIT sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key